BioSpace News Archive

Anatomage Inc, a market leader in 3D medical virtualization technology, releases the Anatomage Dog - the world’s most detailed dog cadaver.

Medidata, a Dassault Systèmes company, today announced it is allowing sponsors, CROs (contract research organizations), and sites to leverage its proprietary Patient Centricity by Design process for clinical trials.

ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company (“ImmunityBio”), today announced the successful completion of its acquisition of the leasehold interest in an ISO Class 5 pharmaceutical manufacturing space in western New York from global pharmaceutical company Athenex, Inc. (NASDAQ: ATNX).

IMIDomics, Inc., a privately held global biotechnology company focused on the discovery and development of new targets and medicines for the treatment of patients with immune-mediated inflammatory diseases (IMIDs), announced today that Evotec SE (FSE: EVT; MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) has made an equity investment in the company.

T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the successful amendment and extension to its Term Loan Agreement with CRG Servicing LLC (“CRG”).

Parse Biosciences, a company dedicated to providing scalable single-cell sequencing solutions, today announced $41.5M in Series B funding co-led by Marshall Wace and Janus Henderson Investors.

PharmaJet®, a biotech company that has developed a more effective way of administering drugs and biologics with their innovative, needle-free injection technology, announced that their partner, Technovalia, has reported interim safety results from their needle-free SARS-CoV2 DNA vaccine phase 1 trial.

The Fact.MR market study on the medical dynamometer market provides deep dive into key developments in the medical dynamometer market.

In a recent market study, Fact.MR covers recent developments in the global ornithine transcarbamylase deficiency treatment market, highlighting vital aspects such as trends, drivers, opportunities, and restraints.

Cutaneous squamous cell carcinoma (cSCC) is a form of skin cancer which involves malignant proliferation of keratinizing cells of the epidermis and its appendages.